Latest California Healthline Stories
Patients are often told to be smart consumers and shop around for health care before they use it. What happens when people actually take that advice?
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what’s been a growing free-market bonanza.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.